194 related articles for article (PubMed ID: 24021228)
1. Four-arm PEG cross-linked hyaluronic acid hydrogels containing PEGylated apoptotic TRAIL protein for treating pancreatic cancer.
Byeon HJ; Choi SH; Choi JS; Kim I; Shin BS; Lee ES; Park ES; Lee KC; Youn YS
Acta Biomater; 2014 Jan; 10(1):142-50. PubMed ID: 24021228
[TBL] [Abstract][Full Text] [Related]
2. Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model.
Byeon HJ; Choi SH; Choi JS; Kim TH; Lee ES; Lee KC; Youn YS
Biomed Pharmacother; 2014 Feb; 68(1):65-9. PubMed ID: 24268811
[TBL] [Abstract][Full Text] [Related]
3. PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy.
Byeon HJ; Kim I; Choi JS; Lee ES; Shin BS; Youn YS
Int J Nanomedicine; 2015; 10():739-48. PubMed ID: 25632232
[TBL] [Abstract][Full Text] [Related]
4. In situ facile-forming PEG cross-linked albumin hydrogels loaded with an apoptotic TRAIL protein.
Kim I; Choi JS; Lee S; Byeon HJ; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
J Control Release; 2015 Sep; 214():30-9. PubMed ID: 26188152
[TBL] [Abstract][Full Text] [Related]
5. Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis.
Kim YJ; Chae SY; Jin CH; Sivasubramanian M; Son S; Choi KY; Jo DG; Kim K; Chan Kwon I; Lee KC; Park JH
Biomaterials; 2010 Dec; 31(34):9057-64. PubMed ID: 20813405
[TBL] [Abstract][Full Text] [Related]
6. PEGylated TNF-related apoptosis-inducing ligand (TRAIL) analogues: pharmacokinetics and antitumor effects.
Kim TH; Youn YS; Jiang HH; Lee S; Chen X; Lee KC
Bioconjug Chem; 2011 Aug; 22(8):1631-7. PubMed ID: 21751817
[TBL] [Abstract][Full Text] [Related]
7. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic Acid Based Hydrogels Attenuate Inflammatory Receptors and Neurotrophins in Interleukin-1β Induced Inflammation Model of Nucleus Pulposus Cells.
Isa IL; Srivastava A; Tiernan D; Owens P; Rooney P; Dockery P; Pandit A
Biomacromolecules; 2015 Jun; 16(6):1714-25. PubMed ID: 25871410
[TBL] [Abstract][Full Text] [Related]
9. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.
Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC
J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635
[TBL] [Abstract][Full Text] [Related]
10. Effect of 3D matrix compositions on the efficacy of EGFR inhibition in pancreatic ductal adenocarcinoma cells.
Ki CS; Shih H; Lin CC
Biomacromolecules; 2013 Sep; 14(9):3017-26. PubMed ID: 23889305
[TBL] [Abstract][Full Text] [Related]
11. Effect of cross-linking reagents for hyaluronic acid hydrogel dermal fillers on tissue augmentation and regeneration.
Yeom J; Bhang SH; Kim BS; Seo MS; Hwang EJ; Cho IH; Park JK; Hahn SK
Bioconjug Chem; 2010 Feb; 21(2):240-7. PubMed ID: 20078098
[TBL] [Abstract][Full Text] [Related]
12. Effects of bound versus soluble pentosan polysulphate in PEG/HA-based hydrogels tailored for intervertebral disc regeneration.
Frith JE; Menzies DJ; Cameron AR; Ghosh P; Whitehead DL; Gronthos S; Zannettino AC; Cooper-White JJ
Biomaterials; 2014 Jan; 35(4):1150-62. PubMed ID: 24215733
[TBL] [Abstract][Full Text] [Related]
13. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
[TBL] [Abstract][Full Text] [Related]
14. Injectable hyaluronic acid-tyramine hydrogels incorporating interferon-α2a for liver cancer therapy.
Xu K; Lee F; Gao SJ; Chung JE; Yano H; Kurisawa M
J Control Release; 2013 Mar; 166(3):203-10. PubMed ID: 23328125
[TBL] [Abstract][Full Text] [Related]
15. Injectable hybrid hydrogels of hyaluronic Acid crosslinked by well-defined synthetic polycations: preparation and characterization in vitro and in vivo.
Cross D; Jiang X; Ji W; Han W; Wang C
Macromol Biosci; 2015 May; 15(5):668-81. PubMed ID: 25630277
[TBL] [Abstract][Full Text] [Related]
16. Interstitial chemotherapy with ricin-loaded thermosensitive hydrogel in pancreatic cancer xenograft.
Chen ZK; Lin LW; Weng XH; Xue ES; Lin YH
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):418-23. PubMed ID: 19666413
[TBL] [Abstract][Full Text] [Related]
17. Site-specific PEGylation of a mutated-cysteine residue and its effect on tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL).
Pan LQ; Wang HB; Lai J; Xu YC; Zhang C; Chen SQ
Biomaterials; 2013 Dec; 34(36):9115-23. PubMed ID: 23981355
[TBL] [Abstract][Full Text] [Related]
18. A sulfate polysaccharide/TNF-related apoptosis-inducing ligand (TRAIL) complex for the long-term delivery of TRAIL in poly(lactic-co-glycolic acid) (PLGA) microspheres.
Kim H; Jeong D; Kang HE; Lee KC; Na K
J Pharm Pharmacol; 2013 Jan; 65(1):11-21. PubMed ID: 23215683
[TBL] [Abstract][Full Text] [Related]
19. PEGylated TNF-related apoptosis-inducing ligand (TRAIL) for effective tumor combination therapy.
Jiang HH; Kim TH; Lee S; Chen X; Youn YS; Lee KC
Biomaterials; 2011 Nov; 32(33):8529-37. PubMed ID: 21855130
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic Acid Hydrogel Functionalized with Self-Assembled Micelles of Amphiphilic PEGylated Kartogenin for the Treatment of Osteoarthritis.
Kang ML; Jeong SY; Im GI
Tissue Eng Part A; 2017 Jul; 23(13-14):630-639. PubMed ID: 28338415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
